- Home
- NVNI vs MIRA Comparison
NVNI vs MIRA Comparison
Compare NVNI & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- MIRA
- Stock Information
- Founded
- NVNI 2019
- MIRA 2020
- Country
- NVNI Brazil
- MIRA United States
- Employees
- NVNI N/A
- MIRA N/A
- Industry
- NVNI
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- MIRA Health Care
- Exchange
- NVNI Nasdaq
- MIRA Nasdaq
- Market Cap
- NVNI 31.5M
- MIRA 19.5M
- IPO Year
- NVNI N/A
- MIRA 2023
- Fundamental
- Price
- NVNI $0.37
- MIRA $1.66
- Analyst Decision
- NVNI
- MIRA Strong Buy
- Analyst Count
- NVNI 0
- MIRA 2
- Target Price
- NVNI N/A
- MIRA $14.00
- AVG Volume (30 Days)
- NVNI 1.2M
- MIRA 3.1M
- Earning Date
- NVNI 08-07-2025
- MIRA 08-12-2025
- Dividend Yield
- NVNI N/A
- MIRA N/A
- EPS Growth
- NVNI N/A
- MIRA N/A
- EPS
- NVNI N/A
- MIRA N/A
- Revenue
- NVNI $31,250,627.00
- MIRA N/A
- Revenue This Year
- NVNI $12.05
- MIRA N/A
- Revenue Next Year
- NVNI $15.02
- MIRA N/A
- P/E Ratio
- NVNI N/A
- MIRA N/A
- Revenue Growth
- NVNI 1491.58
- MIRA N/A
- 52 Week Low
- NVNI $0.14
- MIRA $0.62
- 52 Week High
- NVNI $12.19
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- NVNI 54.74
- MIRA 73.89
- Support Level
- NVNI $0.31
- MIRA $1.07
- Resistance Level
- NVNI $0.36
- MIRA $1.39
- Average True Range (ATR)
- NVNI 0.03
- MIRA 0.14
- MACD
- NVNI 0.01
- MIRA 0.04
- Stochastic Oscillator
- NVNI 80.84
- MIRA 90.77
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.